SAB BIOTHERAPEUTICS INC (SABS) Stock Balance Sheet
NASDAQ:SABS • US78397T2024
Current stock price
3.75 USD
-0.03 (-0.79%)
At close:
3.748 USD
0 (-0.05%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 10.50M | 8.90M | 56.57M | 15.05M | 33.21M | |||
| Marketable Securities | 86.09M | 11.86M | N/A | N/A | N/A | |||
| Receivables | 946.80K | 55.00K | 0.00 | 5.56M | 8.01M | |||
| Other Current Assets | 3.51M | 2.98M | 2.34M | 1.49M | 8.97M | |||
| Total Current Assets | 101.05M | 23.79M | 58.91M | 22.10M | 50.19M | |||
| Non-Current Assets | ||||||||
| PPE Net | 19.41M | 19.92M | 24.68M | 28.34M | 30.95M | |||
| Investments And Advances | 46.89M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 5.46M | 482.10K | 350.00K | 468.00K | 0.00 | |||
| Total Non-Current Assets | 71.76M | 20.40M | 25.03M | 28.81M | 30.95M | |||
| TOTAL ASSETS | 172.81M | 44.20M | 83.94M | 50.91M | 81.14M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 154.00K | 418.40K | 1.18M | 905.00K | 1.96M | |||
| Accrued Expenses | 7.38M | 5.87M | 7.32M | 10.36M | 13.38M | |||
| Accounts Payable | 3.15M | 1.69M | 946.00K | 3.68M | 4.46M | |||
| Other Current Liabilities | N/A | 0.00 | 1.36M | 50.00K | 6.66M | |||
| Total Current Liabilities | 10.68M | 7.98M | 10.81M | 14.99M | 26.45M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.12M | 3.28M | 3.42M | 4.17M | 3.76M | |||
| Other Non-Current Liabilities | 7.51M | 6.97M | 12.41M | 682.00K | 12.37M | |||
| Total Non-Current Liabilities | 10.63M | 10.25M | 15.83M | 4.85M | 16.14M | |||
| TOTAL LIABILITIES | 21.32M | 18.23M | 26.64M | 19.85M | 42.59M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -110.90M | -124.17M | -90.06M | -47.87M | -29.13M | |||
| Additional Paid In Capital | 267.72M | 155.79M | 152.86M | 84.44M | 67.67M | |||
| Common Shares | 4.80K | 1.00K | 1.00K | 5.00K | 4.00K | |||
| Treasury Stock | -5.52M | -5.52M | -5.52M | -5.52M | 0.00 | |||
| Other Shareholders' Equity | 186.50K | -135.40K | 26.00K | N/A | N/A | |||
| Shares Outstanding | 47.61M | 9.29M | 9.22M | 5.04M | 4.35M | |||
| Tangible Book Value per Share | 3.18 | 2.80 | 6.21 | 6.16 | 8.86 | |||
| Total Shareholders' Equity | 151.49M | 25.97M | 57.30M | 31.06M | 38.55M | |||
| TOTAL LIABILITIES AND EQUITY | 172.81M | 44.20M | 83.94M | 50.91M | 81.14M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.13 | 0.06 | 0.13 | 0.10 | |||
| Current Ratio | 9.46 | 2.98 | 5.45 | 1.47 | 1.90 | |||
| Return On Assets (ROA) | 2.47% | -77.17% | -50.27% | -36.82% | -21.13% | |||
| Return On Equity (ROE) | 2.81% | -131.33% | -73.64% | -60.34% | -44.47% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21